News

Mr Pauli has been CFO of OctoPlus since January 1, 2003. The executive board will aim to fill the vacancy of CFO as soon as possible. Simon Sturge,

The committee consists of John Kapoor, chairman of the board of directors and directors Randall Wall and Jerry Ellis. Dr Kapoor said: “Our current management team will execute

Under the agreement, Fujirebio Diagnostics will develop and manufacture for Abbott the HE4 biomarker, a simple blood test that may help in the risk stratification of women at

Prior to joining Synergetics, Mr Hable served as president and CEO of Afferent, a venture capital backed medical device company focused on neuro stimulation therapies. Previously, Mr Hable

Based on the special protocol assessment agreement (SPA), Inspire has initiated a Phase III, randomized, placebo-controlled, environmental clinical trial to evaluate the efficacy and safety of Prolacria in

Under the terms of this financing, investments will be made in three tranches: $12 million before March 31, 2009, $12 million before December 31, 2009 and $12 million

The AdnaTest diagnostic and analytical products for breast and colon cancer are aimed at improving cancer prognosis and patient management. The tests are based on immunomagnetic selection of

Additionally, the company will conduct a voluntary recall of most of its products. The scope and depth of the recall are currently under discussion with the FDA. These

Irinotecan is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy. This product is available for